Ceera Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-59,416
Closed -$1.48M 99
2025
Q4
$1.48M Sell
59,416
-746
-1% -$18.8K 0.57% 39
2025
Q3
$1.53M Buy
60,162
+595
+1% +$14.7K 0.48% 47
2025
Q2
$1.44M Buy
59,567
+3,065
+5% +$71.5K 0.44% 50
2025
Q1
$1.43M Buy
56,502
+11,105
+24% +$291K 0.49% 46
2024
Q4
$1.2M Sell
45,397
-6,654
-13% -$180K 0.41% 49
2024
Q3
$1.51M Buy
52,051
+6,065
+13% +$177K 0.57% 44
2024
Q2
$1.29M Buy
45,986
+2,783
+6% +$76.6K 0.54% 44
2024
Q1
$1.2M Buy
43,203
+11,300
+35% +$314K 0.53% 45
2023
Q4
$918K Sell
31,903
-27,930
-47% -$844K 0.43% 44
2023
Q3
$1.98M Buy
59,833
+17,435
+41% +$617K 1.08% 28
2023
Q2
$1.56M Buy
42,398
+7,675
+22% +$299K 0.9% 34
2023
Q1
$1.42M Buy
34,723
+8,785
+34% +$379K 0.9% 35
2022
Q4
$1.33M Sell
25,938
-5,240
-17% -$251K 0.84% 45
2022
Q3
$1.36M Hold
31,178
0.91% 41
2022
Q2
$1.64M Sell
31,178
-90
-0.3% -$4.59K 0.93% 38
2022
Q1
$1.62M Sell
31,268
-2,220
-7% -$115K 0.81% 36
2021
Q4
$1.98M Buy
33,488
+1,710
+5% +$84.7K 1.02% 35
2021
Q3
$1.37M Buy
31,778
+2,030
+7% +$89.9K 0.75% 38
2021
Q2
$1.17M Buy
29,748
+5,126
+21% +$199K 0.88% 33
2021
Q1
$892K Buy
+24,622
New +$874K 0.73% 34

Other funds holding PFE

Ceera Investments's PFE Position: Q1 2026 in Review

Ceera Investments sold out of Pfizer (PFE) in Q1 2026, closing a stake of 59,416 shares — an estimated $1.48M sold.

Ceera Investments first reported a position in PFE in Q1 2021 and held it in 20 quarters. The position peaked at $1.98M in Q3 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Ceera Investments reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Ceera Investments sold 59,416 Pfizer shares in Q1 2026, an estimated $1.48M.
  • Ceera Investments first reported a position in Pfizer in Q1 2021 and held it in 20 quarters.
  • Ceera Investments's Pfizer position peaked at $1.98M in Q3 2023.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ceera Investments's 13F filing for Q1 2026, filed 6 May 2026.